Drug repurposing in KRAS G12C-mutant NSCLC: a focus on resistance mechanisms and clinical strategies.

Journal: Naunyn-Schmiedeberg's archives of pharmacology •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Jain A, Rosell R, Dharmashekara C, et al. (2026). "Drug repurposing in KRAS G12C-mutant NSCLC: a focus on resistance mechanisms and clinical strategies.". Naunyn-Schmiedeberg's archives of pharmacology. https://doi.org/10.1007/s00210-026-05533-0